Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

Simple Text Block

You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.

Parents always take care of their children’s physical needs. They feed them with nutritious foods and always dress up their wounds immediately. However, they fail to notice the deteriorating mental health of their child. Mostly so, because they do not give it that much importance. It is due to a lack of awareness amongst people.
Even amongst adults, you never know what a person is going through mentally.

Thus, we need to be able to recognize the signs of mental illnesses. A laughing person does not equal a happy person. We must not consider mental illnesses as a taboo and give it the attention it deserves to save people’s lives.

Pursuing progress against advanced prostate cancer

Joining a clinical trial is an important and personal decision. Your doctor may have mentioned the TALAPRO-3 study, or perhaps you found your way here by yourself. To qualify for this study, you may not have received certain anti-cancer treatments, such as:
  • platinum-based chemotherapy within the past 5 years
  • a novel hormone therapy (NHT), such as enzalutamide, or abiraterone/prednisone, or apalutamide if taken for more than 3 months
  • a PARP inhibitor (PARPi)
  • androgen deprivation treatment for more than 3 months
Condition
metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Age
18+ years
Number of study visits
Upto 25
Length of study
About 3 years

About the Clinical Trials

Each facet of our study is designed with patient-centered care, scientific rigor, and innovation in mind. These six elements encapsulate our collaborative approach to advancing diabetes treatment. Each symbol illustrates a unique feature.
Patient care icon

Patient Care

Individual patient well-being remains central. Personalized monitoring guarantees optimum health engagement.
Innovative treatments icon

Innovative Treatments

Exploring potentially revolutionary diabetes treatments through vaccination trials.
Knowledgeable insights icon

Knowledgeable Insights

Keeping participants informed and educated about the trial's progress and advancements.
Medication trials icon

Medication Trials

Testing novel medications for their effectiveness and safety in controlling diabetes.

Find a site near you